| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Neurológico
> Esclerosis múltiple | Asociación regulatoria
> Trabajando con organismos reguladores | 5000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | Endocrino
> Diabetes e hipertensión | Asociación regulatoria
> Con otros defensores de la salud | 10.000 | National | Sometimes | 119045009637 |
| We are one of three founding members of the South African Non-Communicable Disease Association. | Endocrino
> Diabetes e hipertensión | Asociación regulatoria
> Con otros defensores de la salud | 10.000 | National | Sometimes | 119051187994 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Neurológico
> Esclerosis múltiple | Impactando en políticas y legislación
> Influir en la política sanitaria y la legislación | 5000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | Cáncer
> Cáncer: la mayoría de los tipos | Impactando en políticas y legislación
> Influir en la política sanitaria y la legislación | 10.000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cáncer
> Cáncer: la mayoría de los tipos | Impactando en políticas y legislación
> Participar en audiencias públicas y consultas | 10.000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Neurológico
> Esclerosis múltiple | Defensa de precios y asequibilidad
> Abogar por precios justos de los medicamentos | 5000 | Regional | Regularly | 119035905477 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | Reumático
> Espondiloartritis axial | Defensa de precios y asequibilidad
> Abogar por precios justos de los medicamentos | Over 100,000 | National | Regularly | 119051166861 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cáncer
> Cáncer: la mayoría de los tipos | Defensa de precios y asequibilidad
> Participar en negociaciones con el comité de revisión de precios | 10.000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cáncer
> Cáncer: la mayoría de los tipos | Defensa de precios y asequibilidad
> Abogando por la inclusión del producto en listas de reembolso/formularios nacionales | 10.000 | National | Regularly | 119044111428 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | Reumático
> Espondiloartritis axial | Defensa de precios y asequibilidad
> Abogando por la inclusión del producto en listas de reembolso/formularios nacionales | Over 100,000 | National | Regularly | 119051166861 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Neurológico
> Esclerosis múltiple | Mejora de las vías de acceso
> Facilitar el acceso equitativo a medicamentos/atención sanitaria | 5000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | Cáncer
> Cáncer: la mayoría de los tipos | Mejora de las vías de acceso
> Facilitar el acceso equitativo a medicamentos/atención sanitaria | 10.000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cáncer
> Cáncer: la mayoría de los tipos | Aportaciones del paciente basadas en evidencia
> Utiliza los conocimientos del paciente para tomar decisiones | 10.000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Neurológico
> Esclerosis múltiple | Aportaciones del paciente basadas en evidencia
> Proporcionar evidencia del mundo real (RWE) a las agencias reguladoras | 5000 | Regional | Regularly | 119035905477 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. Our input is informed by lived experience, patient-reported challenges, and international collaboration through global MS networks, ensuring that patient needs, equity, and sustainability are considered in decision-making processes. | Neurológico
> Esclerosis múltiple | Aportaciones del paciente basadas en evidencia
> Aprovechar las historias de pacientes y los relatos de experiencias vividas | 5000 | Regional | Regularly | 119035905477 |
| Have engaged the Department of Health. | Raro
> Enfermedades raras: inmune | Gobernanza institucional
> Garantizar la representación en los órganos consultivos gubernamentales | 100 | International | Rarely | 119036013383 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Neurológico
> Esclerosis múltiple | Gobernanza institucional
> Trabajar de manera efectiva dentro de redes con múltiples partes interesadas | 5000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | Endocrino
> Diabetes e hipertensión | Gobernanza institucional
> Mantener el estatus formal como entidad de interés público o benéfica | 10.000 | National | Sometimes | 119045009637 |